157 related articles for article (PubMed ID: 8725996)
1. Rifapentine is active in vitro and in vivo against Toxoplasma gondii.
Araujo FG; Khan AA; Remington JS
Antimicrob Agents Chemother; 1996 Jun; 40(6):1335-7. PubMed ID: 8725996
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
Romand S; Della Bruna C; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
[TBL] [Abstract][Full Text] [Related]
3. The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.
Araujo FG; Khan AA; Slifer TL; Bryskier A; Remington JS
Antimicrob Agents Chemother; 1997 Oct; 41(10):2137-40. PubMed ID: 9333038
[TBL] [Abstract][Full Text] [Related]
4. Rifabutin is active in murine models of toxoplasmosis.
Araujo FG; Slifer T; Remington JS
Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii.
Olliaro P; Gorini G; Jabes D; Regazzetti A; Rossi R; Marchetti A; Tinelli C; Della Bruna C
J Antimicrob Chemother; 1994 Nov; 34(5):649-57. PubMed ID: 7706160
[TBL] [Abstract][Full Text] [Related]
6. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
Khan AA; Lambert LH; Remington JS; Araujo FG
Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
[TBL] [Abstract][Full Text] [Related]
7. Effect of 3-bromopyruvate and atovaquone on infection during in vitro interaction of Toxoplasma gondii and LLC-MK2 cells.
de Lima LP; Seabra SH; Carneiro H; Barbosa HS
Antimicrob Agents Chemother; 2015 Sep; 59(9):5239-49. PubMed ID: 26077255
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
Luft BJ
Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
[TBL] [Abstract][Full Text] [Related]
9. Quinupristin-dalfopristin is active against Toxoplasma gondii.
Khan AA; Slifer TR; Araujo FG; Remington JS
Antimicrob Agents Chemother; 1999 Aug; 43(8):2043-5. PubMed ID: 10428933
[TBL] [Abstract][Full Text] [Related]
10. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
Araujo FG; Huskinson J; Remington JS
Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
12. Ketolide ABT-773 is active against Toxoplasma gondii.
Khan AA; Araujo FG; Craft JC; Remington JS
J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
[TBL] [Abstract][Full Text] [Related]
13. Trovafloxacin is active against Toxoplasma gondii.
Khan AA; Slifer T; Araujo FG; Remington JS
Antimicrob Agents Chemother; 1996 Aug; 40(8):1855-9. PubMed ID: 8843293
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
Alves CF; Vitor RW
Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
[TBL] [Abstract][Full Text] [Related]
15. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
16. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis.
Moshkani SK; Dalimi A
Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
[TBL] [Abstract][Full Text] [Related]
19. Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection.
Ferreira RA; Oliveira AB; Gualberto SA; Vitor RW
Parasite; 2002 Sep; 9(3):261-9. PubMed ID: 12375370
[TBL] [Abstract][Full Text] [Related]
20. Anti-parasitic activity of Annona muricata L. leaf ethanolic extract and its fractions against Toxoplasma gondii in vitro and in vivo.
Miranda NC; Araujo ECB; Justino AB; Cariaco Y; Mota CM; Costa-Nascimento LA; Espindola FS; Silva NM
J Ethnopharmacol; 2021 Jun; 273():114019. PubMed ID: 33716084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
